Status:
UNKNOWN
PCOS, Therapy and Markers of Cardiovascular Risk
Lead Sponsor:
Medical University of Gdansk
Conditions:
PCOS
Eligibility:
FEMALE
18-35 years
Phase:
PHASE4
Brief Summary
In addition to chronic anovulation and hyperandrogenemia, polycystic ovary syndrome (PCOS) is also characterized by peripheral insulin resistance and hyperinsulinaemia, which in turn lead to the devel...
Eligibility Criteria
Inclusion
- PCOS
Exclusion
- diabetes
- pregnancy
- contraindications to oral contraceptives
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01798875
Start Date
April 1 2012
End Date
December 1 2015
Last Update
March 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Clinical and Experimental Endocrinology, Medical University of Gdansk
Gdansk, Poland